From this, we hypothesize that the active substance β-elemene regulates the expression of the potential molecular markers VDR and VEGFC by acting on PTGS1 and PTGS2 to affect anoikis in NSCLC cells. The gene discussed is VDR; the disease is non-small cell lung carcinoma.